In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Prestige acquires 17 noncore OTC products from GSK for £426mm

Executive Summary

Nearly a year after announcing plans to divest noncore OTC brands, GlaxoSmithKline PLC has sold a group of 17 products on the market in the US and Canada to Prestige Brands Holdings Inc. (consumer health care and cleaning products) for £426mm ($660mm). Besides Prestige, many other suitors were rumored to have had their eyes on the assets, including Stada, private equity firm Thomas H. Lee Partners, and VC Bain Capital.
Deal Industry
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Reverse Licensing
    • Product Purchase

Related Companies

Advertisement
UsernamePublicRestriction

Register